SEC Form 4 · accession 0001123292-18-001054
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Oct 26, 2018
Accepted (ET)
Nov 5, 2018 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 26, 2018 | A | 60,000 | $0.00 | A | 151,485 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award subject to repurchase by Aradigm Corporation until such time as such shares vest. The shares of restricted stock vest in four equal quarterly installments over a period of one year beginning on October 26, 2018, subject to the reporting person continuing to be a Participant (as defined in the Aradigm Corporation 2015 Equity Incentive Plan) on each relevant vesting date.